On one hand, CDK8 inhibition induces TIMP3 via SMAD-regulated upregulation of miR-181b, which constitutes the primary mechanism underlying the impact of CDK8 on the growth of liver metastases in colon cancer. This evidence concerns the gene CDK8 and colonic neoplasm.